Patents by Inventor Niranjan B. Pandey

Niranjan B. Pandey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7579356
    Abstract: The present invention is directed to novel thia-tetraazaacenaphthylene compounds of Formula (I): and pharmaceutically acceptable forms thereof and their synthesis and use as inhibitors of ATP-protein kinase interactions.
    Type: Grant
    Filed: April 10, 2006
    Date of Patent: August 25, 2009
    Assignee: Janssen Pharmaceutica NV
    Inventors: Kathleen A. Battista, Gilles C. Bignan, Peter J. Connolly, Stuart Hayden, Sigmond G. Johnson, Ronghui Lin, Niranjan B. Pandey, Mark T. Powell
  • Publication number: 20080300264
    Abstract: The present invention is directed to substituted thiatriazaacenaphthylene-6-carbonitrile compounds of formula (I): and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
    Type: Application
    Filed: August 14, 2008
    Publication date: December 4, 2008
    Inventors: Peter J. Connolly, Stuart L. Emanuel, Stuart Hayden, Sigmond G. Johnson, Bharat Lagu, Steven A. Middleton, Niranjan B. Pandey, Mark T. Powell
  • Patent number: 7427625
    Abstract: The present invention is directed to substituted thiatriazaacenaphthylene-6-carbonitrile compounds of formula (I): and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
    Type: Grant
    Filed: February 7, 2007
    Date of Patent: September 23, 2008
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: Peter J. Connolly, Stuart L. Emanuel, Stuart Hayden, Sigmond G. Johnson, Bharat Lagu, Steven A. Middleton, Niranjan B. Pandey, Mark T. Powell
  • Publication number: 20080108611
    Abstract: The present invention is directed to thienopyrimidine compounds of formula (I): and forms thereof, their synthesis and use for treating, preventing or ameliorating a chronic or acute protein kinase mediated disease, disorder or condition.
    Type: Application
    Filed: January 10, 2007
    Publication date: May 8, 2008
    Inventors: Kathleen A. Battista, Gilles C. Bignan, Peter J. Connolly, Stuart L. Emanuel, Stuart Hayden, Sigmond G. Johnson, Ronghui Lin, Steven A. Middleton, Niranjan B. Pandey, Mark T. Powell